Skip to main content
OpenTrials
Completed

NCT Number: NCT01265706

Livalo Acute Myocardial Infarction Study (LAMIS)

This study is performed to observe the incidence of major cardiovascular events in Korean patients with AMI after giving pitavastatin 2mg and 4mg longer than 1 year.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Myocardial Infarction

Sex eligibility

All sexes

Study type

Observational

Primary location

Chonnam National University Hospital

Gwangju, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with STEMI, NSTEMI
  • Patients satisfying at least one of the followings
  • Patients with LDL-C ≥ 130 mg/dL
  • Patients with LDL-C ≥ 100 mg/dL who are regarded as required cholesterol lowering therapy by the investigator
  • Patients taking statin are required continuous cholesterol lowering therapy
  • Patients satisfying at least two of the followings
  • The change of Ischemic ECG
  • CK, CK-MB, Troponin-I increased more than two times
  • The symptom of ACS

Exclusion criteria

  • Patients with in-stent restenosis after PCI or coronary artery bypass
  • Patients with cardiogenic shock
  • Patients with severe heart failure (Left ventricular ejection fraction is less than 30%)
  • Patients who are taking cyclosporine
  • Patients who experienced hypersensitivity to pitavastatin
  • Patients under dialysis treatment
  • Patients who are participating other clinical trials
  • Patients who can not stop taking concomitant drugs
  • Pregnant or lactating women or suspected pregnancy
  • Patients who are regarded as ineligible for this study by the investigator

Treatment and study plan

Primary outcomes

  1. Incidence of TLR-MACE for 1 year after enrollment

    Time frame: 1 year after enrollment

Secondary outcomes

  1. Incidence of TVR-MACE for 1 year after enrollment

    Time frame: 1 year after enrollment

Sponsors and collaborators

Lead sponsor

JW Pharmaceutical

Industry

Registry information

Official study title

1-year, Prospective, Randomized, Open-label, Parallel Group Observational Study to Evaluate the Safety and Efficacy of 4mg/Day of Pitavastatin Versus 2mg/Day of Pitavastatin in Acute Myocardial Infarction(AMI)

Important dates

Study start
2010
Primary completion
2014
Study completion
2014
First posted
Dec 23, 2010
Registry last updated
Dec 15, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.